Enrico Derenzini

25PUBLICATIONS
141CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 17, 2026
Venetoclax in Combination With Chemo-Immunotherapy in Richter Transformation: A Real-Life Experience.

|Jul 16, 2026
Heteroplasmic variants of mitochondrial genome in tumor and normal samples from patients with hematologic malignancies.

|Jul 13, 2026
Targeting DNA interstrand crosslinks repair with synthetic lethality in High-Grade B-Cell Lymphoma.

|Feb 18, 2026
MACOP-B in Adult Langerhans Cell Histiocytosis Confirms Durable Organ Responses at an Updated Long-Term Follow-Up.

Alessandro Broccoli, Enrico Derenzini, Lisa Argnani

|Feb 11, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Naveen Pemmaraju, Giovanni Marconi, Pau Montesinos

|Jan 14, 2026
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.

Lisa Argnani, Cinzia Pellegrini, Ombretta Annibali

Pageof 5

Frequent Collaborators

3 joint publications

Isacco Ferrarini

3 joint publications

Anna Maria Frustaci

3 joint publications

Valentina Tabanelli

3 joint publications

Roberto Marasca